News
33 % rise in women seeking perinatal mental health support since 2022
One in five new and expectant mothers may be affected by perinatal mental health conditions
In a significant uptick reflecting growing awareness and acceptance of mental health challenges among new...
News
Pharmacy First vital to amplify NHS digital prescription rollout, WHO report reveals
75 per cent of adults in England are registered for digital prescriptions on the NHS App
In a groundbreaking...
News
Haleon to close Maidenhead manufacturing site affecting 435 jobs
Despite the closure, Haleon will retain its presence in the UK with corporate offices in Weybridge and London
Haleon,...
Locum rates: PDA cautions against ‘deliberate breaches’ of NHS contract
The PDA has raised concerns over the 'deliberate breaches' of the NHS contract by some community pharmacy businesses, saying that it may cause harm...
Boots identifies error with PILs of Decongestant Tablets
The Medicines and Healthcare products Regulatory Agency (MHRA) has advised healthcare professionals to ensure appropriate patient counselling takes place and patients are aware of...
NHS booster booking opens for 12-15 year-olds
The NHS booster bookings is now open for 12 to 15 year-olds, who are most at risk from COVID, including those who are severely...
King’s Fund report prompts NPA to call for re-think of PCN pharmacist roles
The recent report by the King’s Fund has led the National Pharmacy Association (NPA) to renew its call for a re-think of PCN pharmacist...
Health and social care leaders sign shared commitment to improve public involvement in research
The health and social care leaders from various organisations in the UK, led by the Health Research Authority (HRA) and National Institute for Health...
RPS urges government to ban ‘diet drug’ DNP for human consumption
The Royal Pharmaceutical Society (RPS) is calling on the Home Office to ban the industrial chemical 2,4-Dinitrophenol (DNP), stating it to be unfit for...
AVICENNA CONFERENCE: Pharmacy regulator to pilot new inspection regime as it rebalances resources
The General Pharmaceutical Council (GPhC) is set to launch a new approach to its routine inspections as it looks to rebalance its resources with...
UK regulator approves Bayer’s Kerendia to treat chronic kidney disease
German pharmaceutical company Bayer has received authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for the use of Kerendia (finerenone) (10mg or...
Avicenna Conference: Shame pharmacists have no say over Category M, says Dr Bharat Shah
Avicenna Conference: Dr Bharat Shah CBE regrets that neither community pharmacists nor pharmaceutical wholesalers in the UK have any control over how Category M...
Sajid Javid shares agenda on healthcare reform; pharmacy bodies pledge support
The NHS is facing a range of long term challenges which needs to be countered with prevention, enhance personalized care and sustainable performance, health...